Ruben Mesa/LinkedIn
Jul 26, 2024, 12:17
Ruben Mesa’s work on how to keep up the pace of timely drug development – Levine Cancer
Levine Cancer shared a post on X:
“Survivors are living longer thanks to new anticancer therapies, so the Overall Survival endpoint is a critical focus of oncology trials.
Dr. Ruben Mesa worked at Clinical Cancer Research and the American Association for Cancer Research on a paper detailing how to keep up the pace of timely drug development.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 20, 2024, 18:34
Dec 20, 2024, 17:52
Dec 20, 2024, 17:31
Dec 20, 2024, 17:31
Dec 20, 2024, 17:22
Dec 20, 2024, 17:18